@article{10902/34708,
year = {2024},
url = {https://hdl.handle.net/10902/34708},
organization = {FUNDING: This project was supported in part by AbbVie; AIRC under 5 per Mille 2018-ID. 21198 program (to PG and GG); PNRR-MAD-2022-12375673 (Next Generation EU, M6/C2_CALL 2022), Italian Ministry of Health, Rome, Italy, Conceptual development of research organization (FNBr 65269705) provided by the Ministry of Health of the Czech Republic, and National Institute for Cancer Research (Programme EXCELLES, ID Project No. LX22NPO5102) funded by the European Union—Next Generation EU.},
publisher = {Wolters Kluwer Health},
publisher = {HemaSphere, 2024, 8(9), e70004},
title = {Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: an international study of ERIC, the European Research Initiative on CLL},
author = {Chatzikonstantinou, Thomas and Scarfò, Lydia and Minga, Eva and Karakatsoulis, Georgios and Chamou, Dimitra and Kotaskova, Jana and Iacoboni, Gloria and Demosthenous, Christos and Albi, Elisa and Alcoceba, Miguel and Al-Shemari, Salem and Aurran-Schleinitz, Thérèse and Bacchiarri, Francesca and Chatzileontiadou, Sofia and Collado, Rosa and Davis, Zadie and Deus Santos, Marcos Daniel de and Dreta, Barbara and Yáñez San Segundo, Lucrecia},
}